IP Library Assignment 069835/0704
Patent Assignment
Reel/Frame 069835/0704

Release of Intellectual Property Security Agreement Recorded at R/F 63227/0852

Recorded: 2025-01-07 Pages: 9
Assignor
NEWSTONE CAPITAL PARTNERS, LLC
Executed: 2025-01-07
Assignee
TERSERA THERAPEUTICS LLC
520 LAKE COOK RD, SUITE 500, DEERFIELD, ILLINOIS, 60015
Covered Properties (33)
Method for Reducing Pain
Patent: 7,268,109 →
Application: 10/956,252 →
Publication: US 2005/0192218
Multicyclic Amino Acid Derivatives and Methods of Their Use
Patent: 7,723,345 →
Application: 11/638,677 →
Publication: US 2007/0191370
Process for the Preparation of Substituted Phenylalanines
Patent: 7,855,291 →
Application: 11/647,517 →
Publication: US 2009/0048280
Automatically Operable Safety Shield System for Syringes
Patent: 7,500,964 →
Application: 11/740,598 →
Publication: US 2007/0191783
Pharmaceutical Formulation Comprising Ziconotide
Patent: 7,524,812 →
Application: 11/831,696 →
Publication: US 2007/0269528
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds and Methods of Their Use
Patent: 7,553,840 →
Application: 11/954,000 →
Publication: US 2008/0153852
Methods of Using and Compositions Comprising Tryptophan Hydroxylase Inhibitors
Patent: 8,093,291 →
Application: 12/144,953 →
Publication: US 2009/0005382
Methods and Compositions for Treating Pulmonary Hypertension and Related Diseases and Disorders
Patent: 7,875,622 →
Application: 12/169,815 →
Publication: US 2009/0054308
Solid Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)-Pyrimidin-4-Yl)Phenyl)Propanoate and Methods of Their Use
Patent: 8,193,204 →
Application: 12/237,455 →
Publication: US 2009/0088447
Process for the Preparation of Substituted Phenylalanines
Patent: 7,897,763 →
Application: 12/257,558 →
Publication: US 2009/0118505
4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds and Methods of Their Use
Patent: 7,709,493 →
Application: 12/468,974 →
Publication: US 2009/0286817
Pharmaceutical Formulations for Reducing Pain
Patent: 7,833,973 →
Application: 12/483,673 →
Publication: US 2009/0247452
1-Phenyl-1H-Pyrazole-Based Compounds
Patent: 7,968,729 →
Application: 12/732,311 →
Publication: US 2010/0240906
Multicyclic Amino Acid Derivatives and Methods of Their Use
Patent: 8,063,057 →
Application: 12/750,278 →
Publication: US 2010/0280054
Methods of Using 4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds
Patent: 7,968,559 →
Application: 12/754,341 →
Publication: US 2010/0311764
Method for Reducing Pain with Ziconotide and Morphine
Patent: 7,977,307 →
Application: 12/898,516 →
Publication: US 2011/0021436
Method for Reducing Pain with Ziconotide and Baclofen
Patent: 7,956,030 →
Application: 12/898,525 →
Publication: US 2011/0021437
Methods of Treating Pulmonary Hypertension
Patent: 8,410,121 →
Application: 13/006,592 →
Publication: US 2011/0112094
Compounds Useful in the Preparation of Tryptophan Hydrroxylase Inhibitors
Patent: 8,450,532 →
Application: 13/024,469 →
Publication: US 2011/0130564
Methods of Preparing 4-Phenyl-6-(2,2,2-Trifluoro-1-Phenylethoxy)Pyrimidine-Based Compounds
Patent: 8,575,362 →
Application: 13/160,678 →
Publication: US 2011/0301349
4-Phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-Based Compounds and Methods of Their Use
Patent: 8,772,482 →
Application: 13/162,989 →
Publication: US 2012/0041008
Method for Reducing Pain
Patent: 8,268,774 →
Application: 13/176,568 →
Publication: US 2012/0003290
Solid Forms of (S)-2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)Pyrimidin-4-Yl)Phenyl)Propanoic Acid
Patent: 8,772,483 →
Application: 13/288,366 →
Publication: US 2012/0122904
Tryptophan Hydroxylase Inhibitors
Patent: 8,629,156 →
Application: 13/290,261 →
Publication: US 2012/0157484
Solid Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)-Pyrimidin-4-Yl)Phenyl)Propanoate and Methods of Their Use
Patent: 8,653,094 →
Application: 13/486,103 →
Publication: US 2013/0005754
Pharmaceutical Formulation for Reducing Pain
Patent: 8,513,198 →
Application: 13/616,607 →
Publication: US 2013/0096066
Method for Administering Omega-Conopeptide
Patent: 8,653,033 →
Application: 13/791,715 →
Publication: US 2013/0225499
Method for Administering Omega-Conopeptide
Patent: 8,765,680 →
Application: 14/133,303 →
Publication: US 2014/0107038
Method for Administering Omega-Conopeptide
Patent: 9,707,270 →
Application: 14/788,524 →
Publication: US 2015/0374787
Method for Administering Omega-Conopeptide
Application: 15/651,655 →
Publication: US 2017/0312337
Method for Administering Omega-Conopeptide
Application: 16/402,145 →
Publication: US 2019/0255148
Solid Dosage Forms of (S)-Ethyl 2-Amino-3-(4-(2-Amino-6-((R)-1-(4-Chloro-2-(3-Methyl-1H-Pyrazol-1-Yl)Phenyl)-2,2,2-Trifluoroethoxy)Pyrimidin-4-Yl)Phenyl)Propanoate
Application: 16/688,658 →
Publication: US 2021/0008068
Method of Treating Cancer with Telotrisat or a Prodrug Thereof
Application: 17/317,120 →
Publication: US 2021/0353624
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Aug 6, 2012
From: EUSA PHARMA (USA), INC.; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMAEUTICALS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 028724/0604 →
Corrective Assignment to Correct the Assignee's Address from 3180 Porter Dr, Palo Alto, California 94304 Previously Recorded on Reel 030182 Frame 0254. Assignor(S) Hereby Confirms the Correct Address to Be Clarendon House 2 Church Street, Hamilton, Bermuda HM11. Jul 12, 2013
From: AZUR PHARMA INTERNATIONAL LIMITED
To: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 030792/0876 →
Security Agreement Jun 19, 2015
From: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 035936/0200 →
Release of Security Interest Jul 9, 2015
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: EUSA PHARMA (USA), INC.; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS, INC.
Reel/Frame 036089/0633 →
Assignment of Assignor's Interest Mar 2, 2017
From: DEVASAGAYARAJ, AROKIASAMY; JIN, HAIHONG; SHI, ZHI-CAI; TUNOORI, ASHOK
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 041444/0250 →
Assignment of Assignor's Interest Mar 2, 2017
From: DEVASAGAYARAJ, AROKIASAMY; JIN, HAIHONG; SHI, ZHI-CAI; TUNOORI, ASHOK
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 041442/0635 →
Assignment of Assignor's Interest Mar 30, 2017
From: ASTRAZENECA AB
To: TERSERA THERAPEUTICS LLC
Reel/Frame 041802/0137 →
Security Interest Apr 10, 2017
From: TERSERA THERAPEUTICS LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041939/0487 →
Security Interest Apr 14, 2017
From: TERSERA THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 042007/0871 →
Change of Name Jun 8, 2017
From: AZUR PHARMA INTERNATIONAL LIMITED
To: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED
Reel/Frame 042652/0988 →
Assignment of Assignor's Interest Jun 8, 2017
From: ELLIS, DAVID J.; MILJANICH, GEORGE P.; SHIELDS, DAVID E.
To: ELAN PHARMACEUTICALS
Reel/Frame 042652/0818 →
Assignment of Assignor's Interest Jun 8, 2017
From: ELAN PHARMACEUTICALS, INC.
To: AZUR PHARMA INTERNATIONAL LIMITED
Reel/Frame 042652/0938 →
Security Interest Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
Assignment of Assignor's Interest Oct 12, 2018
From: JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED
To: TERSERA THERAPEUTICS LLC
Reel/Frame 047150/0760 →
Security Interest Sep 9, 2020
From: TERSERA THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 053721/0037 →
Assignment of Assignor's Interest Sep 14, 2020
From: LEXICON PHARMACEUTICALS, INC.
To: TERSERA THERAPEUTICS LLC
Reel/Frame 053763/0754 →
Release of Security Interest Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
Security Interest Sep 30, 2020
From: TERSERA THERAPEUTICS LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 053940/0001 →
Release of Security Interest May 5, 2021
From: BANK OF AMERICA, N.A.
To: JAZZ PHARMACEUTICALS, INC.; JAZZ PHARMACEUTICALS IRELAND LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL LIMITED; JAZZ PHARMACEUTICALS INTERNATIONAL III LIMITED
Reel/Frame 056150/0708 →
Security Interest Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
Security Interest Apr 4, 2023
From: TERSERA THERAPEUTICS LLC
To: ANTARES CAPITAL LP, AS AGENT
Reel/Frame 063215/0724 →
Release of Security Interest Apr 4, 2023
From: NEWSTONE CAPITAL PARTNERS, LLC
To: TERSERA THERAPEUTICS LLC; JDP THERAPEUTICS LLC
Reel/Frame 063221/0546 →
Release of Security Interest Apr 4, 2023
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: TERSERA THERAPEUTICS LLC
Reel/Frame 063253/0942 →
Security Interest Apr 5, 2023
From: TERSERA THERAPEUTICS LLC
To: NEWSTONE CAPITAL PARTNERS, LLC
Reel/Frame 063227/0852 →
Assignment of Assignor's Interest Aug 9, 2023
From: LEXICON PHARMACEUTICALS, INC.
To: TERSERA THERAPEUTICS, LLC
Reel/Frame 064538/0033 →